Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 10;24(1):70.
doi: 10.1186/s12879-023-08968-5.

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Kevin Komakech  1 , Lydia Nakiyingi  2 , Ashab Fred  3 , Beatrice Achan  1 , Moses Joloba  3 , Bruce J Kirenga  4 , Willy Ssengooba  5   6
Affiliations

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Kevin Komakech et al. BMC Infect Dis. .

Abstract

Background: Mixed M. tuberculosis (MTB) infection occurs when one is infected with more than one clonally distinct MTB strain. This form of infection can assist MTB strains to acquire additional mutations, facilitate the spread of drug-resistant strains, and boost the rate of treatment failure. Hence, the presence of mixed MTB infection could affect the performance of some rapid molecular diagnostic tests such as Line Probe Assay (LPA) and GeneXpert MTB/RIF (Xpert) assays.

Methods: This was a cross-sectional study that used sputum specimens collected from participants screened for STREAM 2 clinical trial between October 2017 and October 2019. Samples from 62 MTB smear-positive patients and rifampicin-resistant patients from peripheral health facilities were processed for Xpert and LPA as screening tests for eligibility in the trial. From November 2020, processed stored sputum samples were retrieved and genotyped to determine the presence of mixed-MTB strain infection using a standard 24-locus Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem-Repeat (MIRU-VNTR). Samples with at least 20/24 MIRU-VNTR loci amplified were considered for analysis. Agar proportional Drug Susceptibility Test (DST) was performed on culture isolates of samples that had discordant results between LPA and Xpert. The impact of the presence of mixed-MTB strain on Xpert and LPA test interpretation was analyzed.

Results: A total of 53/62 (85%) samples had analyzable results from MIRU-VNTR. The overall prevalence of mixed-MTB infection was 5/53 (9.4%). The prevalence was highest among male's 3/31 (9.7%) and among middle-aged adults, 4/30 (33.3%). Lineage 4 of MTB contributed 3/5 (60.0%) of the mixed-MTB infection prevalence. Having mixed MTB strain infection increased the odds of false susceptible Xpert test results (OR 7.556, 95% CI 0.88-64.44) but not for LPA. Being HIV-positive (P = 0.04) independently predicted the presence of mixed MTB infection.

Conclusions: The presence of mixed-MTB strain infection may affect the performance of the GeneXpert test but not for LPA. For patients with high pre-test probability of rifampicin resistance, an alternative rapid method such as LPA should be considered.

Keywords: Accuracy; GeneXpert; LPA; Mixed MTB infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Update of

Similar articles

See all similar articles

Cited by

References

    1. Bagcchi S. WHO's global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. - DOI - PubMed
    1. World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization; 2023. Available at: https://www.who.int/publications/i/item/9789240083851. Accessed 9 Jan 2024.
    1. Van't Hoog A, Viney K, Biermann O, Yang B, Leeflang MM, Langendam MW. Symptom-and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status. Cochrane Database Syst Rev. 2022;3 - PMC - PubMed
    1. World Health Organization. Systematic screening for active tuberculosis: an operational guide. Geneva: World Health Organization; 2015. Available at: https://www.who.int/publications/i/item/9789241549172. Accessed 9 Jan 2024.
    1. Wang G, Wang S, Jiang G, Yang X, Huo F, Ma Y, Dai G, Li W, Chen X, Huang H. Xpert MTB/RIF ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study. J Infect. 2019;78(4):311–316. doi: 10.1016/j.jinf.2019.02.010. - DOI - PubMed